-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Nearly 2,000 people have been vaccinated! "Lizhu Bio's recombinant novel coronavirus fusion protein vaccine" is being promoted and vaccinated in our city
Published Time:
2022-12-11
Recently
Jointly developed by Lizhu Bio and the Institute of Biophysics, Chinese Academy of Sciences
A new vaccine
—"Lizhu Bio Recombinant Novel Coronavirus Fusion Protein Vaccine"
has been officially promoted for vaccination in our city
Nearly 2,000 people have been vaccinated
At Lizhu Group Limin Pharmaceutical Factory, the reporter met Huang Wenhua, the factory director and senior engineer. According to him, Lizhu Bio launched the Lizhu Bio recombinant novel coronavirus fusion protein vaccine project in July 2020. In September 2022, the Lizhu Bio recombinant novel coronavirus fusion protein vaccine developed and produced by this project was officially included in the national COVID-19 immunization program.
Lizhu Bio Recombinant Novel Coronavirus Fusion Protein Vaccine
The Lizhu Bio recombinant novel coronavirus fusion protein vaccine is the world's first COVID-19 vaccine to pass Phase III clinical trials and achieve high protection against Omicron. Data shows that the vaccine has good safety and excellent protection. Based on two doses of inactivated vaccines, the absolute protection rate against Omicron after sequential booster vaccination with the Lizhu Bio recombinant novel coronavirus fusion protein vaccine is 61.35%, which is comparable to the effect of mRNA vaccine booster immunization, and is particularly suitable for the elderly, high-risk occupational groups and people with underlying diseases.
Citizens register for COVID-19 vaccination at Shaoguan No. 2 People's Hospital.
Wang Weijie, member of the Party group of Wujiang District Health and Health Bureau:
To our understanding, currently, the sequential vaccination of people over 60 years old in Wujiang District mainly uses vaccines from Lizhu Bio and Anhui Zhifei. Both vaccines can produce good protective effects, effectively reducing the severity of infection in the elderly, and no adverse reactions have been reported. Therefore, for citizens who have not yet received a booster shot, we recommend sequential vaccination, or homologous vaccination. Based on current feedback, the effects of Lizhu Bio and Anhui Zhifei vaccines are better.
Citizens receive COVID-19 vaccination at Shaoguan No. 2 People's Hospital.
Huang Wenhua:
The Lizhu Bio recombinant novel coronavirus fusion protein vaccine can be used as a third dose for booster immunization. People aged 18 and above who have completed the full course of basic immunization (meaning they have completed two doses of inactivated vaccine) for more than 3 months can choose to receive this vaccine. Like other vaccines, there are some people who are not suitable for vaccination, such as those with a history of serious allergic reactions to vaccines, pregnant and lactating women, etc. Citizens should follow the guidance of medical staff before vaccination.
Currently
Some vaccination sites in counties (cities, districts) across the city
can choose to vaccinate with the Lizhu Bio recombinant novel coronavirus fusion protein vaccine
Citizens in need can go to the vaccination sites to learn more and get vaccinated
Text: Shaoguan Daily All-Media Reporter Du Haitao
Pictures/Videos: He Lijian
Editor: Li Jianqun
Editor in charge: Wang Lurong
Transferred from: Shaoguan News Network
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home